Lin281632
CAS No. 108825-65-6
Lin281632( Lin28 1632 | Lin-28 1632 | Lin 28 163 )
Catalog No. M27896 CAS No. 108825-65-6
Lin281632 is an inhibitor of RNA binding protein Lin28 and bromodomain. Lin281632 promotes mESC differentiation.
Purity : >98% (HPLC)
Size | Price / USD | Stock | Quantity |
5MG | 80 | Get Quote |
|
10MG | 140 | Get Quote |
|
25MG | 295 | Get Quote |
|
50MG | 507 | Get Quote |
|
100MG | 714 | Get Quote |
|
500MG | 1503 | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameLin281632
-
NoteResearch use only, not for human use.
-
Brief DescriptionLin281632 is an inhibitor of RNA binding protein Lin28 and bromodomain. Lin281632 promotes mESC differentiation.
-
DescriptionLin281632 is an inhibitor of RNA binding protein Lin28 and bromodomain. Lin281632 promotes mESC differentiation.
-
In Vitro——
-
In Vivo——
-
SynonymsLin28 1632 | Lin-28 1632 | Lin 28 163
-
PathwayOthers
-
TargetOther Targets
-
Recptormannitol-1-phosphate dehydrogenase (M1PDH)
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number108825-65-6
-
Formula Weight281.319
-
Molecular FormulaC15H15N5O
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 50 mg/mL (177.74 mM)
-
SMILESCN(C(C)=O)c1cccc(c1)-c1ccc2nnc(C)n2n1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
Scutebarbatine B
Scutebarbatine B shows weak cytotoxicity with IC50 values ranging from 35.11 to 42.73 μM against K562 cell lines and HL60 cell lines.
-
DCZ0415
DCZ0415 induces antimyeloma activity in vitro, in vivo and in primary cells of drug-resistant myeloma patients. DCZ0415 is a potent TRIP13 inhibitor that can impair the repair of non-homologous end junctions and inhibit NF-κB activity.DCZ0415 (10, 20 μM; 72 hours) showed a marked reduction in colony formation, indicating that it inhibited cell proliferation.
-
Caulilexin C
Caulilexin C shows inhibitory activity on human Acyl CoA: cholesterol transferase I (hACATI) and on human Acyl CoA: cholesterol transferase 2 (hACAT2) at 100 mug/ml.